TSBP Logo

CE Opportunity — Virtual Pharmacist Opioid Symposium (June 2021)

The Texas State Board of Pharmacy is pleased to partner with the Drug Enforcement Administration (DEA) Dallas Field Division to bring this pharmacy-oriented continuing education program to Texas pharmacy professionals. Learn more here.



* * * * * * *SCAM ALERT NOTICE* * * * * * *

TSBP continues to receive reports of scams involving individuals impersoning state agency entities. The most recent scam reports to TSBP indicate instances of telephone scammers spoofing TSBP's phone number so that the calls appear to be originating from TSBP directly. Learn more about these scams and see an example scam letter here.


Coronavirus Updates:
Visit us at www.pharmacy.texas.gov/coronavirus for news and resources for both
consumers and pharmacy professionals regarding COVID-19


Recent TSBP COVID-19 Highlights
  • Pharmacies must enroll in the Texas Department of State Health Services (DSHS) Immunization Program to be eligible to administer COVID-19 vaccines in Texas once they are available. Learn more here.
  • Pharmacists are allowed to order and administer immunizations to children 3-18 years of age as authorized by the third amendment to the PREP Act under certain conditions. Learn more here.
  • Pharmacist-interns acting under the supervision of a pharmacist and pharmacy technicians acting under the supervision of a pharmacist are allowed to administer immunizations to children 3-18 years of age, provided that the vaccination is ordered by the supervising pharmacist as authorized by the third amendment to the PREP Act under certain conditions. Learn more here.


On March 13, 2020, Governor Greg Abbott declared a state of disaster for all Texas Counties as a result of the COVID-19 (coronavirus) pandemic. In planning for the agency's response, the health and safety of the public and of our employees is of utmost concern. The offices of the Texas State Board of Pharmacy are open and operational, and we will continue to perform the essential functions of our agency while providing the highest level of service possible. Please note that many agency employees are working remotely. The best way to contact the office is by email. A list of agency emails can be found here.




Updates, News & Notices     Visit TSBP Newsroom


CE Opportunity — Virtual Pharmacist Opioid Symposium

The Texas State Board of Pharmacy is pleased to partner with the Drug Enforcement Administration (DEA) Dallas Field Division to bring this pharmacy-oriented continuing education program to Texas pharmacy professionals.

The symposium will be held in June 2021 and offers three (3) hours (0.3 CEUs) of CE approved by the Texas State Board of Pharmacy for license renewal. This program may be counted toward the requirement of prescribing and monitoring controlled substances as outlined by Board rule 295.8 for pharmacists and toward Texas-specific pharmacy laws or rules for pharmacy technicians per Board rule 297.8.

Visit our annoucement page for details and registration information:
▸ Virtual Pharmacist Opioid Symposium
▸ Symposium FAQs

April 30, 2021

 

Podcast Launch — TSBP Talks

TSBP has launched a new podcast to bring you Board news and updates. Listen to our first episode here:
▸ TSBP Talks

April 9, 2021

Scam Alert Notice — UPDATE: April 2021

TSBP continues to receive reports of scams involving individuals impersoning state agency entities. The most recent scam reports to TSBP indicate instances of telephone scammers spoofing TSBP's phone number so that the calls appear to be originating from TSBP directly. Remember that TSBP staff does NOT request your personal information in unsolicited phone calls. TSBP will NEVER request money or bank account information in a phone call. You may report information on telephone scammers to the Texas OAG.
▸ Read the Texas OAG release regarding these types of scams
▸ Learn more about reporting scammers
▸ Click here to see an example scam letter

April 7, 2021

Compounding Advisory Group to Discuss FDA MOU in June 2021 - Stakeholder Input Requested

The Board discussed the U.S. Food and Drug Administration (FDA) Memorandum of Understanding (MOU) at the February 2021 Board meeting and voted to add the MOU to the Compounding Advisory Group agenda at their upcoming meeting in June 2021. The upcoming Compounding Advisory Group meeting will elicit input from stakeholders regarding the MOU, and together with stakeholder input provide a recommendation to the Board for consideration at the August 2021 Board meeting. Compounding Advisory Group schedules and agendas are posted here as they become available:
▸ Compounding Advisory Group schedule & agenda information

February 25, 2021


Additional Important Information